Bristol-Myers Squibb: Robert Wood Johnson University Hospital Honors Bristol-Myers Squibb as “Champions for Children”
 
Robert Wood Johnson University Hospital Honors Bristol-Myers Squibb as “Champions for Children”

Company Recognized for Support of Bristol-Myers Squibb Children’s Hospital at 10th Anniversary

Bristol-Myers Squibb Children’s Hospital at Robert Wood Johnson University Hospital
The Bristol-Myers Squibb Children’s Hospital at Robert Wood Johnson University Hospital, New Brunswick, New Jersey.
Bristol-Myers Squibb was honored recently for its support of the Bristol-Myers Squibb Children’s Hospital at Robert Wood Johnson University Hospital (RWJUH), which is celebrating its 10th anniversary this year.

RWJUH President and CEO Stephen K. Jones joined hospital Board of Directors President John Hoffman in celebrating the company as “Our Champions for Children” during the hospital’s October 15 Autumn Ball at the Heldrich Hotel in New Brunswick.

“Over the past decade, Bristol-Myers Squibb has made an indelible impact on our children’s hospital, our growing pediatric health campus and in the lives of thousands of children,” said Jones. “We are proud to call them our partners and to honor them as our Champions for Children.”

“Just as we look at our own children in amazement at how fast they grow, it is hard to believe the Bristol-Myers Squibb Children’s Hospital is 10 years old – or even that there was once a time when New Jersey did not have a freestanding children’s hospital of its own,” said John E. Celentano, senior vice president, Human Resources, Public Affairs and Philanthropy, Bristol-Myers Squibb, at the event. “Today, families from across New Jersey come to The Bristol-Myers Squibb Children’s Hospital for the highest level of medical and surgical care in specialties ranging from cardiology and pulmonology to oncology, hematology and urology – all provided in a family-friendly environment.”

Bristol-Myers Squibb, which operates five facilities in central New Jersey, was an early proponent of RWJUH’s plan to build a children’s hospital on its New Brunswick campus that would provide New Jersey families with access to state-of-the-art pediatric care close to home. Over the past decade, contributions from Bristol-Myers Squibb and its Foundation have helped support construction of the hospital; the creation of three clinical centers of excellence for the treatment of serious pediatric health issues such as HIV/AIDS, rheumatoid arthritis and lupus, and metabolic disorders including childhood obesity; and expansion of the hospital’s pediatric surgery services.

The Bristol-Myers Squibb Children’s Hospital at RWJUH has emerged over that time as a regional resource for specialized pediatric care serving families from New Jersey and beyond. It has also spurred other major investments in children’s health in the community. In 2005, the University of Medicine and Dentistry of New Jersey (UMDNJ)-Robert Wood Johnson Medical School opened the 150,000-square-foot Child Health Institute of New Jersey next door to the children’s hospital. PSE&G Children’s Specialized Hospital, a pediatric rehabilitation hospital, opened on a neighboring site two years later. Across the street, a Ronald McDonald House was built to serve the increasing numbers of families who come to the area for care, while the Embrace Kids organization offers support to families whose children have cancer, sickle cell disease or other blood disorders.

Together, these institutions form a pediatric academic health campus unique in New Jersey, bringing together acute care, rehabilitation and research, as well as supportive services for families.

“From everyone in the Bristol-Myers Squibb family to all of our friends in the Robert Wood Johnson University Hospital family, thank you for the opportunity to make a difference in the lives of the children who are so important to all of us. You are the true Champions for Children,” added Celentano.

 
 
 
 


You are leaving BMS.com to go to the Amylin Job Search and application tool. IMPORTANT TO NOTE: This may require a separate login and password than what is used for the Bristol-Myers Squibb search and application process.